Neuroendocrinology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.4 | Q3 | 33.0% | 0.949 | Q2 | 82.5% |
| 2024 | 2.8 | Q3 | 48.7% | 1.094 | Q2 | 86.4% |
| 2023 | 3.2 | Q2 | 58.9% | 1.009 | Q2 | 85.7% |
| 2022 | 4.1 | Q2 | 63.3% | 1.079 | Q1 | 87.9% |
| 2021 | 5.1 | Q2 | 71.6% | 0.993 | Q2 | 86.3% |
| 2020 | — | — | 1.493 | Q1 | 92.3% | |
| 2019 | — | — | 1.738 | Q1 | 94.3% | |
| 2018 | — | — | 2.067 | Q1 | 95.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1423-0194
ISSN
0028-3835
region
Western Europe
coverage
1965, 1967-2026